SCHEMBL5280528

SCHEMBL5280528

O=C(O)CC(c1ccccc1)n1cnc2ccc(NC(=O)C3(c4ccccc4)CCCC3)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.45
LMNA P02545 1/20 0.45
NPY2R P49146 2/20 0.44
HDAC1 Q13547 4/20 0.43
HTT P42858 3/20 0.42
KDM4E B2RXH2 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 1/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KHK P50053 1/20 0.39
HDAC4 P56524 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5287131 0.94 L3MBTL1 (0.45) NPSR1LMNANPY2RHDAC1HTT
SCHEMBL2294510 0.81 SMN1; SMN2 (0.42) NPSR1LMNAHTTKDM4EALDH1A1
SCHEMBL2292264 0.81 NPC1 (0.44) LMNAHTTKDM4EALDH1A1MEN1
SCHEMBL2294482 0.81 NAMPT (0.48) LMNAKDM4EALDH1A1GAAMEN1
SCHEMBL2292578 0.80 KDM4E (0.44) NPSR1LMNANPY2RHTTKDM4E
SCHEMBL2294478 0.80 NPC1 (0.48) LMNAHTTMEN1KMT2ASMN1; SMN2
SCHEMBL5302265 0.80 EPHX2 (0.48) LMNANPY2RKDM4ETDP1ALDH1A1
SCHEMBL2294191 0.79 NPC1 (0.38) NPSR1LMNAGAACYP3A4CYP2D6
SCHEMBL2298594 0.79 KMT2A (0.46) LMNAKDM4EALDH1A1MEN1KMT2A
SCHEMBL2295362 0.79 SMN1; SMN2 (0.43) LMNAHTTKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed